Pharmacokinetic modeling of [(18)F]fluorodeoxyglucose (FDG) for premature infants, and newborns through 5-year-olds

BACKGROUND: Absorbed dose estimates for pediatric patients require pharmacokinetics that are, to the extent possible, age-specific. Such age-specific pharmacokinetic data are lacking for many of the diagnostic agents typically used in pediatric imaging. We have developed a pharmacokinetic model of [...

Descripción completa

Detalles Bibliográficos
Autores principales: Khamwan, Kitiwat, Plyku, Donika, O’Reilly, Shannon E., Goodkind, Alison, Cao, Xinhua, Fahey, Frederic H., Treves, S. Ted, Bolch, Wesley E., Sgouros, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797375/
https://www.ncbi.nlm.nih.gov/pubmed/26988861
http://dx.doi.org/10.1186/s13550-016-0179-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797375/
https://www.ncbi.nlm.nih.gov/pubmed/26988861
http://dx.doi.org/10.1186/s13550-016-0179-6

Ejemplares similares